Madan Jagasia
Faculty Member
Last active: 3/20/2014

  1. Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Engelhardt BG, Sengsayadeth SM, Jagasia M, Savani BN, Kassim AA, Lu P, Shyr Y, Yoder SM, Rock MT, Crowe JE (2012) Exp Hematol 40(12): 974-982.e1
    › Primary publication · 22885125 (PubMed) · PMC3611587 (PubMed Central)
  2. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Sengsayadeth SM, Srivastava S, Jagasia M, Savani BN (2012) Biol Blood Marrow Transplant 18(10): 1479-87
    › Primary publication · 22449611 (PubMed)
  3. Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation. Reddy N, Oluwole O, Greer JP, Goodman S, Engelhardt B, Jagasia MH, Savani BN (2012) Clin Lymphoma Myeloma Leuk 12(6): 406-11
    › Primary publication · 22981964 (PubMed) · PMC4845749 (PubMed Central)
  4. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang MJ, Antin JH, Bolwell BJ, Bredeson C, Cahn JY, Cairo M, Gale RP, Gupta V, Lee SJ, Litzow M, Weisdorf DJ, Horowitz MM, Hahn T (2012) Blood 119(1): 296-307
    › Primary publication · 22010102 (PubMed) · PMC3251233 (PubMed Central)
  5. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP, Goodman SG, Clifton C, Lucid C, Vaughan LA, Savani BN, Jagasia M (2012) Bone Marrow Transplant 47(11): 1470-3
    › Primary publication · 22484321 (PubMed)
  6. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Engelhardt BG, Jagasia SM, Crowe JE, Griffith ML, Savani BN, Kassim AA, Lu P, Weitkamp JH, Moore DJ, Yoder SM, Rock MT, Jagasia M (2012) Blood 119(10): 2417-21
    › Primary publication · 22262764 (PubMed) · PMC3311262 (PubMed Central)
  7. Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. Jagasia MH, Abonour R, Long GD, Bolwell BJ, Laport GG, Shore TB, Durrant S, Szer J, Chen MG, Lizambri R, Waller EK (2012) Bone Marrow Transplant 47(10): 1350-5
    › Primary publication · 22327131 (PubMed)
  8. Minimal residual disease in myeloma: are we there yet? Hart AJ, Jagasia MH, Kim AS, Mosse CA, Savani BN, Kassim A (2012) Biol Blood Marrow Transplant 18(12): 1790-9
    › Primary publication · 22626785 (PubMed)
  9. Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma. Reddy N, Greer JP, Goodman S, Engelhardt B, Oluwole O, Jagasia MH, Savani BN (2012) Bone Marrow Transplant 47(10): 1318-20
    › Primary publication · 22327132 (PubMed) · PMC4845748 (PubMed Central)
  10. Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies. Chinratanalab W, Reddy N, Greer JP, Morgan D, Engelhardt B, Kassim A, Brandt SJ, Jagasia M, Goodman S, Savani BN (2012) Exp Hematol 40(6): 431-5
    › Primary publication · 22269114 (PubMed) · PMC4067702 (PubMed Central)